AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their Covid-19 vaccine, a rare instance of public dissension between major institutions collaborating on a pivotal project.

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose...